Literature DB >> 16392617

F-18 FDG PET in detecting renal cell carcinoma.

I Ak1, C Can.   

Abstract

PURPOSE: To assess the role of F-18 FDG imaging with a dual head coincidence mode gamma camera (Co-PET) in the detection of renal cell carcinoma (RCC) in patients with renal masses.
MATERIAL AND METHODS: An F-18 FDG Co-PET study was performed in 19 patients (7 F, 12 M; mean age 58.15 +/- 2.5 years, age range 45-79 years) with suspected primary renal tumors based on conventional imaging techniques, including computed tomography (CT) and ultrasonography (US) before nephrectomy or surgical resection of the mass.
RESULTS: Histologically documented RCC was present in 15 patients. Of the 19 patients with suspected primary renal tumors, F-18 FDG Co-PET was true-positive in 13, false-negative in 2, true-negative in 3, and false-positive in I patient. Two angiomyolipomas and one renal mass due to infarction and hemorrhage showed a true-negative Co-PET result. The patient with false-positive FDG Co-PET study was diagnosed as xantogranulomatous pyelonephritis. Overall sensitivity, specificity, and accuracy of FDG Co-PET for RCC were 86% (13/15), 75% (3/4), and 84% (16/19), respectively. Positive predictive value for RCC was 92% and negative predictive value 60%.
CONCLUSION: These findings suggest that F-18 FDG Co-PET may have a role in the diagnostic evaluation of patients with RCC and primary staging of disease. Positive F-18 FDG study may be predictive of the presence of RCC. However, a negative study does not exclude the RCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16392617     DOI: 10.1080/02841850500335002

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  7 in total

1.  Pyelo-cystic Reflux in F-18 FDG PET Scan Due to Ureteral Obstruction.

Authors:  Mehmet Reyhan
Journal:  Nucl Med Mol Imaging       Date:  2013-06-11

2.  Incidental Bilateral Renal Oncocytoma in a Patient with Metastatic Carcinoma of Unknown Primary: a Pitfall on (18)F-FDG PET/CT.

Authors:  William Makis; Anthony Ciarallo; Javier-A Novales-Diaz; Robert Lisbona
Journal:  Nucl Med Mol Imaging       Date:  2011-07-13

3.  Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography.

Authors:  Isao Ishikawa; Kyoko Morita; Satoshi Hayama; Tetsuya Nakazawa; Ichiro Araki; Kotaro Higashi; Katsuhito Miyazawa; Koji Suzuki; Takayuki Nojima
Journal:  Clin Exp Nephrol       Date:  2010-09-09       Impact factor: 2.801

4.  Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma.

Authors:  Reiko Nakajima; Koichiro Abe; Tsunenori Kondo; Kazunari Tanabe; Shuji Sakai
Journal:  Eur Radiol       Date:  2015-09-24       Impact factor: 5.315

5.  Photon-deficient Mass on FDG-PET Scan in Renal Cell Carcinoma: A Case Report.

Authors:  George Shih; Wei-Jen Shih; Bonnie Mitchell; Primo P Milan
Journal:  Clin Med Case Rep       Date:  2008-12-23

6.  Can Initial (18)F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma?

Authors:  Haejun Lee; Kyung Hoon Hwang; Seog Gyun Kim; Geon Koh; Ji Hyun Kim
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

7.  In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET.

Authors:  Peter K Wong; Sze Ting Lee; Carmel Murone; John Eng; Nathan Lawrentschuk; Salvatore U Berlangieri; Kunthi Pathmaraj; Graeme J O'Keefe; John Sachinidis; Amanda J Byrne; Damien M Bolton; Ian D Davis; Andrew M Scott
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.